On June 2, 2022 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported that management will participate in two upcoming investor conferences (Press release, Spectrum Pharmaceuticals, JUN 2, 2022, View Source [SID1234615435]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat presentation at the Jefferies Healthcare Conference in New York from 1 to 1:25 p.m. ET on Thursday, June 9, 2022; and,
A fireside chat presentation at the JMP Securities Life Sciences Conference in New York from 9 to 9:25 a.m. ET on Thursday, June 16, 2022.
A live webcast of each presentation will be available on the Investor Relations section of the company’s website at View Source with a replay available shortly after the live event.